|
1
|
Pompeu JE, Romano RS, Pompeu SM and Lima
SM: Static and dynamic balance in subjects with ankylosing
spondylitis: Literature review. Rev Bras Reumatol. 52:409–416.
2012.(In English, Portuguese). PubMed/NCBI
|
|
2
|
Akkoc N, van der Linden S and Khan MA:
Ankylosing spondylitis and symptom-modifying vs disease-modifying
therapy. Best Pract Res Clin Rheumatol. 20:539–557. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Machado P, Landewé R, Braun J, Hermann KG,
Baker D and van der Heijde D: Both structural damage and
inflammation of the spine contribute to impairment of spinal
mobility in patients with ankylosing spondylitis. Ann Rheum Dis.
69:1465–1470. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang M, Yuan H, Miao M and Xu W: The
osteogenic potential of ligament fibroblasts is greater in
ankylosing spondylitis patients than in patients with
osteoarthritis. Z Rheumatol. 74:340–345. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sun Y, Liu M, Yang B, Li B and Lu J: Role
of siRNA silencing of MMP-2 gene on invasion and growth of
laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol.
265:1385–1391. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Noel A, Maillard C, Rocks N, Jost M,
Chabottaux V, Sounni NE, Maquoi E, Cataldo D and Foidart JM:
Membrane associated proteases and their inhibitors in tumour
angiogenesis. J Clin Pathol. 57:577–584. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sun R, Huang Y, Zhang H and Liu R: MMP-2,
TNF-α and NLRP1 polymorphisms in Chinese patients with ankylosing
spondylitis and rheumatoid arthritis. Mol Biol Rep. 40:6303–6308.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kargiotis O, Chetty C, Gondi CS, Tsung AJ,
Dinh DH, Gujrati M, Lakka SS, Kyritsis AP and Rao JS:
Adenovirus-mediated transfer of siRNA against MMP-2 mRNA results in
impaired invasion and tumor-induced angiogenesis, induces apoptosis
in vitro and inhibits tumor growth in vivo in glioblastoma.
Oncogene. 27:4830–4840. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Badiga AV, Chetty C, Kesanakurti D, Are D,
Gujrati M, Klopfenstein JD, Dinh DH and Rao JS: MMP-2 siRNA
inhibits radiation-enhanced invasiveness in glioma cells. PLoS One.
6:e206142011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mello CC and Conte D Jr: Revealing the
world of RNA interference. Nature. 431:338–342. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Khan MA: HLA-B27 and its subtypes in world
populations. Curr Opin Rheumatol. 7:263–269. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu HX, Jiang N, Liang HY, Zhou YY, Feng
XH, Feng XY, Zhang HQ, Wu ZK, Jiang Q, Fu J, et al: Bushen Qiangji
Granule () medicated serum inhibits osteogenic differentiation of
fibroblasts in ankylosing spondylitis by inhibiting the BMP/Smads
signal pathway in vitro. Chin J Integr Med. 22:817–822. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Arnett FC: The seronegative
spondyloarthropathies. Curr Opin Rheumatol. 4:460–462.
1992.PubMed/NCBI
|
|
15
|
Ranganathan K, Loder S, Agarwal S, Wong
VW, Forsberg J, Davis TA, Wang S, James AW and Levi B: Heterotopic
ossification: Basic-science principles and clinical correlates. J
Bone Joint Surg Am. 97:1101–1111. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Touaitahuata H, Cres G, de Rossi S, Vives
V and Blangy A: The mineral dissolution function of osteoclasts is
dispensable for hypertrophic cartilage degradation during long bone
development and growth. Dev Biol. 393:57–70. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schett G: Bone formation versus bone
resorption in ankylosing spondylitis. Adv Exp Med Biol.
649:114–121. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ogawa M and LaRue AC: Origin of fibroblast
colony-forming units. Exp Hematol. 35:1319–1320. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kanazawa I, Yamaguchi T, Yano S, Yamauchi
M, Yamamoto M and Sugimoto T: Adiponectin and AMP kinase activator
stimulate proliferation, differentiation, and mineralization of
osteoblastic MC3T3-E1 cells. BMC Cell Biol. 8:512007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jun JK and Kim SM: Association study of
fibroblast growth factor 2 and fibroblast growth factor receptors
gene polymorphism in korean ossification of the posterior
longitudinal ligament patients. J Korean Neurosurg Soc. 52:7–13.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ducy P, Schinke T and Karsenty G: The
osteoblast: A sophisticated fibroblast under central surveillance.
Science. 289:1501–1504. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang D, Haile A and Jones LC:
Dexamethasone-induced lipolysis increases the adverse effect of
adipocytes on osteoblasts using cells derived from human
mesenchymal stem cells. Bone. 53:520–530. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Karsenty G: Role of Cbfa1 in osteoblast
differentiation and function. Semin Cell Dev Biol. 11:343–346.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ducy P, Starbuck M, Priemel M, Shen J,
Pinero G, Geoffroy V, Amling M and Karsenty G: A Cbfa1-dependent
genetic pathway controls bone formation beyond embryonic
development. Genes Dev. 13:1025–1036. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lories RJ, Derese I and Luyten FP:
Modulation of bone morphogenetic protein signaling inhibits the
onset and progression of ankylosing enthesitis. J Clin Invest.
115:1571–1579. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Massagué J: How cells read TGF-beta
signals. Nat Rev Mol Cell Biol. 1:169–178. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Waite KA and Eng C: From developmental
disorder to heritable cancer: It's all in the BMP/TGF-beta family.
Nat Rev Genet. 4:763–773. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cao X and Chen D: The BMP signaling and in
vivo bone formation. Gene. 357:1–8. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pande V and Ramos MJ: NF-kappaB in human
disease: Current inhibitors and prospects for de novo structure
based design of inhibitors. Curr Med Chem. 12:357–374. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ghosh S and Hayden MS: New regulators of
NF-kappaB in inflammation. Nat Rev Immunol. 8:837–848. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Harada H, Tagashira S, Fujiwara M, Ogawa
S, Katsumata T, Yamaguchi A, Komori T and Nakatsuka M: Cbfa1
isoforms exert functional differences in osteoblast
differentiation. J Biol Chem. 274:6972–6978. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Huang RL, Yuan Y, Tu J, Zou GM and Li Q:
Opposing TNF-α/IL-1β- and BMP-2-activated MAPK signaling pathways
converge on Runx2 to regulate BMP-2-induced osteoblastic
differentiation. Cell Death Dis. 5:e11872014. View Article : Google Scholar : PubMed/NCBI
|
